More Opthea Limited news
Opthea LimitedASX: OPT

ASRS 2023 - PK and safety of sozinibercept (OPT-302)

Jul 31, 2023 at 11:55 PM EDT · Issued by Opthea Limited

Filed with ASX · Jul 31, 2023 at 11:55 PM EDT · 12 pages · English

On 6ix: 6ix.com/news/asrs-2023-pk-and-safety-of-sozinibercept-opt-302

Opthea Limited on 6ix

In the deck

  • Opthea — ASRS 202312 slidesAug 1, 2023

Earlier from Opthea

  • Opthea Receives A$8.7million R&D Tax IncentiveMar 6, 2023
  • Half Year AccountsFeb 22, 2023
  • Response to ASX QueryFeb 16, 2023
  • Opthea Ph2b Trial Results with OPT-302 published in JournalFeb 13, 2023
  • Opthea Corporate Presentation - San Francisco Jan 2023Jan 10, 2023

Later from Opthea

  • Opthea announces A$80m Capital raiseAug 24, 2023
  • Opthea Investor PresentationAug 24, 2023
  • ProspectusAug 24, 2023
  • Opthea completes institutional offer and increases raiseAug 28, 2023
  • Opthea Retail Entitlement Offer OpensAug 30, 2023
All Opthea news releases↗

Follow Opthea into a list and get an email when it puts out news.

Follow Opthea
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer